跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
TAZIME FOR INJECTION 1 g/vial - HSA Drug Approval Details
Approvals
/
HSA
/
TAZIME FOR INJECTION 1 g/vial
Approved
THERAPEUTIC
TAZIME FOR INJECTION 1 g/vial
HANMI PHARM CO LTD
🇸🇬 Health Sciences Authority
Approval Date
Oct 11, 2002
Approval ID
b7cd869cd9601383
Company
HANMI PHARM CO LTD
Type
Therapeutic
Approval Details
Approval Id
b7cd869cd9601383
Drug Name
TAZIME FOR INJECTION 1 g/vial
Product Name
TAZIME FOR INJECTION 1 g/vial
Approval Number
SIN12096P
Approval Date
2002-10-11
Registrant
SHOEI UNIVERSAL CORPORATION PTE LTD
Licence Holder
SHOEI UNIVERSAL CORPORATION PTE LTD
Drug Type
Therapeutic
Forensic Classification
Prescription Only
Dosage Form
INJECTION, POWDER, FOR SOLUTION
Route Of Administration
INTRAVENOUS, INTRAMUSCULAR
Atc Code
J01DD02
Atc Item Name
ceftazidime
Pharma Manufacturer Name
SHOEI UNIVERSAL CORPORATION PTE LTD
Company Detail Path
/organization/shoei-universal-corporation-pte-ltd
Active Ingredients
Ceftazidime pentahydrate with sod. carbonate1.121g/vial eqv Ceftazidime Pentahydrate
1 g/vial
CEFTAZIDIME PENTAHYDRATE WITH SOD. CARBONATE 1.121 G/VIAL EQV CEFTAZIDIME PENTAHYDRATE
1 G/VIAL
Approved
Quick Info
Agency
HSA
Country
🇸🇬
Approval Date
Oct 11, 2002
Approval ID
b7cd869cd9601383
Type
Therapeutic
Back to HSA Approvals